Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Tractor Supply Co (TSCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Tractor Supply Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.78 (market cap $4.49B), while Tractor Supply Co trades at $29.46 (market cap $15.96B). The key difference: Tractor Supply Co is far larger — about 3.6× ACADIA Pharmaceuticals Inc.'s market cap, and Tractor Supply Co pays a 3.15% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | TSCO | |
|---|---|---|
Market Cap | $4.49B | $15.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $28.06 | $62.65 |
52-Week Low | $20.06 | $29.14 |
Enterprise Value | $3.69B | $22.14B |
Dividend Yield | — | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACAD trades at $26.20, up 0.89% today, with strong analyst consensus (70% buy ratings) and a $33.67 price target. Recent CHMP recommendation for Daybue in Europe (Business Wire, June 26, 2026) drove positive sentiment. The stock shows bullish technical signals with moving averages supporting upside, though RSI levels indicate overbought conditions. Fundamentally, revenue grew to $1.07B in 2025 with a robust net income margin of 34.3%, though Q1 2026 earnings missed expectations.
Outlook remains positive given commercial execution and pipeline catalysts like remlifanserin data, but risks include earnings volatility and regulatory dependencies. The stock offers growth potential in neuropsychiatry markets, balanced by execution risks in clinical trials and competitive pressures.
TSCO trades at $30.43, down 4.19% with bearish technical signals. The stock shows mixed fundamentals with revenue growth to $15.52B in 2025 but recent earnings misses. Analyst consensus remains positive with a $44.31 price target. Recent news highlights upcoming Q2 earnings and rural market initiatives.
The outlook balances strong profitability (45.5% ROE) against consumer pressure risks. Upside exists if Q2 earnings beat expectations, but cautious rural spending and margin compression pose near-term headwinds. Valuation at 14.89 P/E offers potential if growth reaccelerates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
